
TRACON Pharmaceuticals Investor Relations Material
Latest events

Q1 2024
TRACON Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TRACON Pharmaceuticals Inc
Access all reports
TRACON Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing targeted therapies for cancer. The company’s approach includes working with partners to advance drug candidates that address unmet medical needs in oncology. TRACON's pipeline consists of small molecules and biologics designed to treat various cancer types by inhibiting tumor growth and progression. The company also offers its expertise in clinical development and regulatory management to support its collaborations. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
TCON
Country
🇺🇸 United States